Evidence map›Paper›PMID 40867241›Full record

ReviewCancers2025

The Role of mHealth Applications in Uro-Oncology: A Systematic Review and Future Directions.

Miguel Ángel Gómez-Luque, Inés Rivero-Belenchón, Carmen Belén Congregado-Ruiz, German Antonio Escobar-Rodríguez, Francisco Javier Delgado-Granados, Jose Antonio Rivas-González, Rafael Antonio Medina-López

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miguel Ángel Gómez-LuqueUrology and Nephrology Department, Virgen del Rocio University Hospital, 41013 Seville, Spain.ORCID 0000-0001-6659-3353
Inés Rivero-BelenchónUrology and Nephrology Department, Virgen del Rocio University Hospital, 41013 Seville, Spain.ORCID 0000-0002-6217-4618
Carmen Belén Congregado-RuizUrology and Nephrology Department, Virgen del Rocio University Hospital, 41013 Seville, Spain.
German Antonio Escobar-RodríguezInnovation and Technology Group, Biomedical Institute of Seville (IBiS), 41013 Seville, Spain.ORCID 0000-0002-3981-8534
Francisco Javier Delgado-GranadosInnovation and Technology Group, Biomedical Institute of Seville (IBiS), 41013 Seville, Spain.
Jose Antonio Rivas-GonzálezInnovation and Technology Group, Biomedical Institute of Seville (IBiS), 41013 Seville, Spain.ORCID 0000-0003-1267-0880
Rafael Antonio Medina-LópezUrology and Nephrology Department, Virgen del Rocio University Hospital, 41013 Seville, Spain.ORCID 0000-0002-4514-4329

Funding

The Foundation for Health Research Management of Seville (FISEVI) None
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

eHealthpatient empowermentprostate canceruro-oncology

Identifiers

PMID40867241
PMCPMC12384193

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.